India: A global strategic asset for developed world market businesses

Journal of Generic Medicines

Volumn 4, Issue 1, 2006, Pages 37-42

  Tempest, Brian ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

AGE; ARTICLE; ASIA; COMPETITION; COST BENEFIT ANALYSIS; DEVELOPED COUNTRY; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; DRUG RESEARCH; ECONOMIC EVALUATION; INDIA; PATENT; PRODUCTIVITY;

EID: 33846876532     PISSN: 17411343     EISSN: 17417090     Source Type: Journal    
DOI: 10.1057/palgrave.jgm.4950046     Document Type: Article

References (25)

1. World Economic Forum annual meeting, Davos, Switzerland, 25th-29th January 2006.
2. Killik and Co. quarterly report (2006).
3. Purushothaman, R. (2004). India: Realizing BRICs Potential, Global Economics Paper No. 109, Goldman Sachs, New York.
4. Institute of Pharmaceutical & Healthcare Management and Research (IPHMR) conference Roundtable on Legal & Regulatory Framework for the Indian Pharmaceutical Industry, New Delhi, August 2004.
5. The Times, London 11 March 2006.
6. Mozeson, M. (2005). Reinventing Big Pharma, Forbes.com. http://www.forbes.com/2005/12/01/merck-pfizer-in_mm_1201soapbox_inl.html accessed 27th July 2006.
7. Karmali, N. (2005). India's Top 40 Methodology Forbes Asia. http://www.forbes.com/global/2005/1226/057A.html accessed 27th July 2006.
8. United Nations Conference on Trade and Development (UNCTAD) (2005). World Investment Report 2005: Transnational Corporations and the Internationalisation of R&D, United Nations, New York & Geneva. Available from http://www.unctad.org/en/docs/wir2005_en.pdf accessed 28th July 2006.
9. The Financial Express (India). Roche gets first product patent in India, 1 March 2006. Available from http://www.financialexpress.com/ fe_full_story.php?content_id=119208 accessed 28th July 2006.
10. Indo-Asian News Service (IANS) (2006). India set to become planet's knowledge hub Available from www.newindpress.com.
11. Royal Society of Chemistry (2004). Laboratories, resources and budgets: provision for science in secondary schools. Available from http://www.rsc.org/images/2004Laboratorie_tcm18-12553.pdf accessed 28th July 2006.
12. World Business February 2006.
13. Computer Industry Almanac Inc. (2006) India: Internet Usage Stats and Telecommunications Market Report, Computer Industry Almanac Inc., Available from www.internetworldstats.com/asia/in.htm accessed 21st July 2006.
14. Social Watch India (2006) Citizen's Report on Governance and Development 2006, Social Watch India. Available from http://www.socialwatch.org/en/ noticiass_112.htm accessed 21st July 2006.
15. JP Morgan Indian bulk filings 1Q06; April 17, 2006.
16. Citigroup Investment Research estimates, (2005) Generic cycle tracker no 3.
17. KPMG (2006) The Indian pharmaceutical industry: Collaboration for growth. Available at http://www.in.kpmg.com/pdf/ Indian%20Pharma%20Outlook.pdf accessed 28th July 2006.
18. JP Morgan Asia Pacific Equity Research, January 16 2006.
19. Indian Pharmaceutical Alliance at 5th Global Generic Strategy Summit, Barcelona, 20-23 March 2006.
20. Wall Street Journal, 15 March 2006.
21. Frost & Sullivan (2004) World Generics and Biogenerics Markets, Frost & Sullivan.
22. Financial Times, June 1 2006.
23. Wertheimer, A.I., Chaney, N.M. & Santella, T. (2003) Counterfeit pharmaceuticals: Current status and future projections. Journal of the American Pharmacists Association 43(6), 710-718.
24. Financial Times.
25. Scrip, 20th February 2006.